Încărcări by all green associates

4040EAP1120268

3776EAP1120274

32734-Article Text-95721-2-10-20201111

1-s2.0-S1878535217300059-main

Mannzhi et al., 2021

PastexamFAC1501Oct2015

FAC1503-2018-10-E-1-1

FAC1503-2019-6-E-1-1

FAC1503-2019-6-E-1

FAC1503-2018-10-E-1.pdf

FAC1503-2018-10-E-1

FAC1503 - TL202_1_2020_b

FAC1503 - TL201_1_2020_b

FAC1503 - TL104_2020_2_b

FAC1503 - TL103_2020_3_b

FAC1503 - TL102_2019_3_b

short tests

CMY1501-2019-6-E-1-1.pdf

CMY1501-2018-10-E-1-1

CMY1501-notes

101_2020_3_b.pdf

001_2018_4_b.pdf

IMWA2010_Gumbo_499

382371_910306817_919389380.pdf

382371_910306817_919389380

IMWA2009_Gumbo_Mulugisi

59669-108662-1-PB-1

WOR73.pdf

Bioavailability of rifampicin in a separate formulation and fixed dose combination with isoniazid NIH_ a case for a fixed dose combination (FDC) fo.

retrospecific analysis of chlorophyll-a

Evaluation_of_the_efficacy_of_

environments-06-00012

8505903

7008EAP1119257Caitlin

693-10212-1-PB

689-10147-1-PB

1-s2.0-S2405844018375091-main

1-s2.0-S0022286019301735-main

DOI10.1016_j.heliyon.2018.e00838

1-s2.0-S2405844018328020-main.pdf

DOI10.1016_j.heliyon.2018.e00838

toxins-10-00269.pdf

toxins-10-00269.pdf

Multiple Questions and Answers prepared by Malesela Leso.pdf

301_2020_4_b.pdf

301_2020_4_b